Viveve Medical, Inc.
VIVE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $73 | $70 | $113 | $115 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $73 | $70 | $113 | $115 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.2% | 9.4% | -3.8% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 32.4% | 16.4% | 19.5% | -2.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -267.8% | -271.4% | -322.4% | -337.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -314.1% | -341.1% | -376.4% | -370.9% |
| EPS Diluted | -0.5 | -0.58 | -0.58 | -0.63 |
| % Growth | 13.8% | 0% | 7.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |